The present invention provides a combination therapy for inhibiting the growth of tumor, for treating cancer, and for inducing cell death. The therapy comprises the sequential administration of taxane and a CDK1 antagonist. The present invention also provides pharmaceutical compositions comprising taxane and a CDK1 antagonist and kits comprising taxane and CDK1 antagonist.

 
Web www.patentalert.com

< P-type semiconductor manufacturing method and semiconductor device

< Multi element, multi color solid state LED/laser

> Gallium-nitride based multi-quantum well light-emitting diode n-type contact layer structure

> Light emitting device with blue light LED and phosphor components
~ 00211